

Nbryo is a cutting-edge biotechnology venture focused on transforming global beef and dairy supply chains through next-generation breeding technologies. With a mission to significantly increase productivity while reducing methane emissions, Nbryo’s platform represents a breakthrough in the way livestock genetics are advanced, scaled, and applied across global agricultural systems.
Founded in 2021 by pharmaceutical entrepreneur Euan Murdoch and genetics innovator Nick Cameron, Nbryo builds on over 15 years of pioneering success in assisted reproduction technologies, developed for Australia’s leading producers.
The company is backed by experienced shareholders and notable venture capital investors within the agtech and agrifood sectors. Its leadership includes Chair Gerard Davis, founder of Catapult Genetics (acquired by Pfizer Inc.), bringing decades of expertise in livestock molecular genetics to guide Nbryo’s growth and commercial trajectory
Research into embryo transfer by Noodooinbah.
Nbyro created.
Major grant funding.
First patent filed on twinning process.
Second patent filed.
First twinned calves born.
Proprietary embryo media developed and trialled
Transfer device prototype design and developed.
Third patent filed.
Pilots with commercial partners
The challenges faced by the world include:
By 2050 the Food and Agriculture Organization estimates thatwe will need
to produce 60% more food to feed an expected 9.7B people.
1.5 bn cattle worldwide account for 9-10% of all green house gases
Livestock supports 40% 0f global agricultural value with 1.3 billion people
relying on livestock for their livelihoods
Natural mating and artificial insemination are slow to make genetic changes
and are difficult to scale.
IVF is very expensive and technically complex currently limited to elite livestock producers.
These systems are worth over US$1.3 trillion and need to transition to lower emissions and greater
sustainability whilst boosting productivity and profitability amid climate challenges.
Accelerating genetic improvement is the most efficient way to address this within the
necessary time frame
There is significant wastage in the system.
Meet the team leading the success of Nbryo.

Founder

Chief Executive Officer

Co-Founder

Chief Financial Officer

Head of Growth and Marketing

Head of Platform
To learn more about Nbryo and their recent updates, visit their website below.

This document provides additional or updated information relating to the original Nbryo Information Memorandum and should be read in conjunction with it. It includes important amendments, clarifications, or disclosures relevant to the investment offering.